161 related articles for article (PubMed ID: 25737084)
1. Internalization of staphylococcal leukotoxins that bind and divert the C5a receptor is required for intracellular Ca(2+) mobilization by human neutrophils.
Tawk MY; Zimmermann K; Bossu JL; Potrich C; Bourcier T; Dalla Serra M; Poulain B; Prévost G; Jover E
Cell Microbiol; 2015 Aug; 17(8):1241-57. PubMed ID: 25737084
[TBL] [Abstract][Full Text] [Related]
2. Above and beyond C5a Receptor Targeting by Staphylococcal Leucotoxins: Retrograde Transport of Panton-Valentine Leucocidin and γ-Hemolysin.
Zimmermann-Meisse G; Prévost G; Jover E
Toxins (Basel); 2017 Jan; 9(1):. PubMed ID: 28117704
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the specificity of Panton-Valentine leucocidin and gamma-hemolysin F component binding.
Meyer F; Girardot R; Piémont Y; Prévost G; Colin DA
Infect Immun; 2009 Jan; 77(1):266-73. PubMed ID: 18838523
[TBL] [Abstract][Full Text] [Related]
4. The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors.
Spaan AN; Henry T; van Rooijen WJM; Perret M; Badiou C; Aerts PC; Kemmink J; de Haas CJC; van Kessel KPM; Vandenesch F; Lina G; van Strijp JAG
Cell Host Microbe; 2013 May; 13(5):584-594. PubMed ID: 23684309
[TBL] [Abstract][Full Text] [Related]
5. LukS-PV induces apoptosis in acute myeloid leukemia cells mediated by C5a receptor.
Zhang P; Yu WW; Peng J; Xu LF; Zhao CC; Chang WJ; Ma XL
Cancer Med; 2019 May; 8(5):2474-2483. PubMed ID: 30955242
[TBL] [Abstract][Full Text] [Related]
6. α-Defensins partially protect human neutrophils against Panton-Valentine leukocidin produced by Staphylococcus aureus.
Cardot-Martin E; Casalegno JS; Badiou C; Dauwalder O; Keller D; Prévost G; Rieg S; Kern WV; Cuerq C; Etienne J; Vandenesch F; Lina G; Dumitrescu O
Lett Appl Microbiol; 2015 Aug; 61(2):158-64. PubMed ID: 25963798
[TBL] [Abstract][Full Text] [Related]
7. LukM/LukF'-PV is the most active Staphylococcus aureus leukotoxin on bovine neutrophils.
Barrio MB; Rainard P; Prévost G
Microbes Infect; 2006 Jul; 8(8):2068-74. PubMed ID: 16782383
[TBL] [Abstract][Full Text] [Related]
8. Panton-Valentine Leukocidin Induces Cytokine Release and Cytotoxicity Mediated by the C5a Receptor on Rabbit Alveolar Macrophages.
Harada S; Kawada H; Maehana S; Matsui H; Kubo M; Kojima F; Kitasato H; Katagiri M
Jpn J Infect Dis; 2021 Jul; 74(4):352-358. PubMed ID: 33518621
[TBL] [Abstract][Full Text] [Related]
9. Human CD45 is an F-component-specific receptor for the staphylococcal toxin Panton-Valentine leukocidin.
Tromp AT; Van Gent M; Abrial P; Martin A; Jansen JP; De Haas CJC; Van Kessel KPM; Bardoel BW; Kruse E; Bourdonnay E; Boettcher M; McManus MT; Day CJ; Jennings MP; Lina G; Vandenesch F; Van Strijp JAG; Lebbink RJ; Haas PA; Henry T; Spaan AN
Nat Microbiol; 2018 Jun; 3(6):708-717. PubMed ID: 29736038
[TBL] [Abstract][Full Text] [Related]
10. The interaction of Staphylococcus aureus bi-component gamma-hemolysins and leucocidins with cells and lipid membranes.
Ferreras M; Höper F; Dalla Serra M; Colin DA; Prévost G; Menestrina G
Biochim Biophys Acta; 1998 Nov; 1414(1-2):108-26. PubMed ID: 9804914
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.
Adhikari RP; Kort T; Shulenin S; Kanipakala T; Ganjbaksh N; Roghmann MC; Holtsberg FW; Aman MJ
PLoS One; 2015; 10(9):e0137874. PubMed ID: 26367030
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric determination of Panton-Valentine leucocidin S component binding.
Gauduchon V; Werner S; Prévost G; Monteil H; Colin DA
Infect Immun; 2001 Apr; 69(4):2390-5. PubMed ID: 11254598
[TBL] [Abstract][Full Text] [Related]
13. Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model.
Karauzum H; Adhikari RP; Sarwar J; Devi VS; Abaandou L; Haudenschild C; Mahmoudieh M; Boroun AR; Vu H; Nguyen T; Warfield KL; Shulenin S; Aman MJ
PLoS One; 2013; 8(6):e65384. PubMed ID: 23762356
[TBL] [Abstract][Full Text] [Related]
14. Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes.
Kaneko J; Kamio Y
Biosci Biotechnol Biochem; 2004 May; 68(5):981-1003. PubMed ID: 15170101
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcus aureus Panton-Valentine leukocidin induces an inflammatory response in human phagocytes via the NLRP3 inflammasome.
Holzinger D; Gieldon L; Mysore V; Nippe N; Taxman DJ; Duncan JA; Broglie PM; Marketon K; Austermann J; Vogl T; Foell D; Niemann S; Peters G; Roth J; Löffler B
J Leukoc Biol; 2012 Nov; 92(5):1069-81. PubMed ID: 22892107
[TBL] [Abstract][Full Text] [Related]
16. Differential Interaction of the Staphylococcal Toxins Panton-Valentine Leukocidin and γ-Hemolysin CB with Human C5a Receptors.
Spaan AN; Schiepers A; de Haas CJ; van Hooijdonk DD; Badiou C; Contamin H; Vandenesch F; Lina G; Gerard NP; Gerard C; van Kessel KP; Henry T; van Strijp JA
J Immunol; 2015 Aug; 195(3):1034-43. PubMed ID: 26091719
[TBL] [Abstract][Full Text] [Related]
17. The staphylococcal pore-forming leukotoxins open Ca2+ channels in the membrane of human polymorphonuclear neutrophils.
Staali L; Monteil H; Colin DA
J Membr Biol; 1998 Apr; 162(3):209-16. PubMed ID: 9543493
[TBL] [Abstract][Full Text] [Related]
18. Control of the oxidative burst of human neutrophils by staphylococcal leukotoxins.
Colin DA; Monteil H
Infect Immun; 2003 Jul; 71(7):3724-9. PubMed ID: 12819053
[TBL] [Abstract][Full Text] [Related]
19. Residues essential for Panton-Valentine leukocidin S component binding to its cell receptor suggest both plasticity and adaptability in its interaction surface.
Laventie BJ; Guérin F; Mourey L; Tawk MY; Jover E; Maveyraud L; Prévost G
PLoS One; 2014; 9(3):e92094. PubMed ID: 24643034
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcus aureus toxin LukSF dissociates from its membrane receptor target to enable renewed ligand sequestration.
Haapasalo K; Wollman AJM; de Haas CJC; van Kessel KPM; van Strijp JAG; Leake MC
FASEB J; 2019 Mar; 33(3):3807-3824. PubMed ID: 30509126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
